Calculating of Correlations Between ADR, PDR, MAP

Colon Neoplasm Clinical Trial

Official title:

Calculating of Correlations Between ADR, PDR, MAP

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03723720
• Other study ID #: MAP
• Status: Completed
• Start date: January 2013
• Est. completion date: December 2017

Study information

• Verified date: March 2023
• Source: Hospital Frydek-Mistek
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of our study is to compare MAP (mean adenoma per colonoscopy) with ADR (adenoma detection rate) and PDR (polyp detection rate) of all colonoscopists in our department

Description:

ADR (adenoma detection rate) is generally accepted quality indicator. For possible gaming with ADR other indicators are needed. MAP (mean adenoma per colonoscopy) reflects the quality of examination of entire colon and is considered to be the most objective quality indicator. The aim of our study is to compare MAP with ADR and PDR (polyp detection rate) of all colonoscopists in our department. We want to retrospectively assess the quality indicators of all colonoscopies from January 2013 to December 2017. We want to calculate ADR, PDR and MAP of all our endoscopists for all colonoscopies in patients over 50 years of age excluding therapeutic, IBD, management of complications and sigmoidoscopies (screening, surveillance, diagnostic) and separately only for screening colonoscopies. Correlations between MAP/ADR and MAP/PDR will be performed using Pearson´s correlation coefficient.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 6925
• Est. completion date: December 2017
• Est. primary completion date: December 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years and older

Eligibility

Inclusion Criteria:

• people over 50 years of age coming for colonoscopic examination (screening, surveillance, diagnostic)

Exclusion Criteria:

• age under 50 years
• indication for colonoscopy: therapeutic, IBD, management of complications and sigmoidoscopies

Related Conditions & MeSH terms

• Colon Neoplasm
• Colonic Neoplasms

Intervention

Device:
• Colonoscopy
Endoscopic examination of large bowel

Locations

Country	Name	City	State
Czechia	Hospital Frydek-Mistek	Frýdek-Místek

Sponsors (1)

Lead Sponsor	Collaborator
Hospital Frydek-Mistek

Country where clinical trial is conducted

Czechia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	correlation between MAP and ADR for all and screening colonoscopies	Pearson´s correlation coefficient	january 2013 - december 2017
Primary	correlation between MAP and PDR for all and screening colonoscopies	Pearson´s correlation coefficient	january 2013 - december 2017
Primary	correlation between ADR and PDR for all and screening colonoscopies	Pearson´s correlation coefficient	january 2013 - december 2017